Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention

被引:125
作者
Ellis, SG [1 ]
Bhatt, D [1 ]
Kapadia, S [1 ]
Lee, D [1 ]
Yen, M [1 ]
Whitlow, PL [1 ]
机构
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
关键词
angioplasty; bleeding; vascular complications;
D O I
10.1002/ccd.20671
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Retroperitoneal hemorrhage (RPH) is an infrequent but occasionally fatal complication of percutaneous coronary intervention (PCI). Therefore, it has been studied in relatively small numbers of patients. Methods: Prospectively collected data on 28,378 consecutive patients treated between 1992 and 2003 were examined, supplemented by a date-based case control cohort study (76 RPH and 76 non-RPH patients) to examine elements not routinely recorded prospectively. Independent correlates of RPH were determined using logistical regression analysis. Results: One hundred sixty-three patients (0.57%) developed RPH; of these 73.5% required blood transfusions and 10.4% expired during hospitalization (P < 0.001 for both compared with patients without RPH). RPH was independently associated with femoral artery sheath placement superior to the inferior epigastric artery (P < 0.001), female sex (P < 0.001), use of Angioseal (TM) Device (P < 0.001), glycoprotein IIb/IIIa inhibitor use (P = 0.001), and patient presentation with the acute myocardial infarction (P = 0.035), and was inversely related to patient weight (P = 0.014). Of the 17 patient deaths, 6 were directly related to RPH, 2 of which occurred in association with delays in resuscitation efforts consequent to attempts to obtain diagnostic confirmation with CT imaging. Conclusions: RPH remains an infrequent but serious complication of PCI. Appropriate management of the femoral access site and the patient once this complication is suspected may minimize adverse outcomes. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:541 / 545
页数:5
相关论文
共 9 条
[1]  
AGUILAR OPM, 2004, INTERVENTIONAL CARDI, P179
[2]   Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade [J].
Cura, FA ;
Kapadia, SR ;
L'Allier, PL ;
Schneider, JP ;
Kreindel, MS ;
Silver, MJ ;
Yadav, JS ;
Simpfendorfer, CC ;
Raymond, RR ;
Tuzcu, EM ;
Franco, I ;
Whitlow, PL ;
Topol, EJ ;
Ellis, SG .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (07) :780-+
[3]   Low-normal or excessive body mass index: Newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention [J].
Ellis, SG ;
Elliott, J ;
Horrigan, M ;
Raymond, RE ;
Howell, G .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (06) :642-646
[4]   Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices [J].
Farouque, HMO ;
Tremmel, JA ;
Shabari, FR ;
Aggarwal, M ;
Fearon, WF ;
Ng, MKC ;
Rezaee, M ;
Yeung, AC ;
Lee, DP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) :363-368
[5]   RETROPERITONEAL HEMATOMA AFTER CARDIAC-CATHETERIZATION - PREVALENCE, RISK-FACTORS, AND OPTIMAL MANAGEMENT [J].
KENT, KC ;
MOSCUCCI, M ;
MANSOUR, KA ;
DIMATTIA, S ;
GALLAGHER, S ;
KUNTZ, R ;
SKILLMAN, JJ ;
SPENCE, RK ;
VEITH, FJ ;
PANETTA, TF ;
ASCER, E ;
RICOTTA, JJ ;
BUSH, HL .
JOURNAL OF VASCULAR SURGERY, 1994, 20 (06) :905-913
[6]   VASCULAR COMPLICATIONS AFTER BALLOON AND NEW DEVICE ANGIOPLASTY [J].
POPMA, JJ ;
SATLER, LF ;
PICHARD, AD ;
KENT, KM ;
CAMPBELL, A ;
CHUANG, YC ;
CLARK, C ;
MERRITT, AJ ;
BUCHER, TA ;
LEON, MB .
CIRCULATION, 1993, 88 (04) :1569-1578
[7]  
SHEREV DA, 2005, CATHETER CARDIOVASC, V65, P203
[8]  
STANDRING S, 2005, GRAYS ANATOMY, P1111
[9]  
*SYSTAT SOFTW INC, 2005, SYSTAT 11 DAT VERS 1